AMO Teledioptric System for age-related macular degeneration

Details AMO Teledioptric System for age-related macular degeneration AMO Teledioptric System for age-related macular degeneration

May 1994

adsabs.harvard.edu/cgi-bin/nph-data_query?bibcode=1994spie.2127..128c&link_type=abstract

Proc. SPIE Vol. 2127, p. 128-135, Ophthalmic Lens Design and Fabrication II, Donn M. Silberman; Ed.

Computer Science

Sound

Scientific paper

A 2.5 X magnification system consisting of a two-zone intraocular implant and a spectacle was developed, tested, and clinically tried by fifty patients with cataract ad age-related macular degeneration. Optical bench testing results and clinical data confirmed that the field of view of the system was 2.6 times wider than an equivalent external telescope. The study also demonstrated that the implant itself was clinically equivalent to a standard monofocal intraocular lens for cataract. The clinical study indicated that higher magnification without compromising the compactness and optical quality was needed as the disease progressed. Also, a sound vision rehabilitation process is important to provide patients the full benefits of the system.

Affiliated with

Also associated with

No associations

Rating

AMO Teledioptric System for age-related macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this scientific paper.

If you have personal experience with AMO Teledioptric System for age-related macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AMO Teledioptric System for age-related macular degeneration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFWR-SCP-O-1681380